Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inflammation and aging: signaling pathways and intervention therapies. | Signal Transduct Target Ther | 2023 | 37291105 | PubTator, text mining | PubMed |
| Synergistic effect of elevated glucose levels with SARS-CoV-2 spike protein induced NOX-dependent ROS production in endothelial cells. | Mol Biol Rep | 2023 | 37289363 | PubTator, text mining | PubMed |
| Single-cell analysis reveals dysregulated inflammatory response in peripheral blood immunity in patients with acute respiratory distress syndrome. | Front Cell Dev Biol | 2023 | 37283946 | PubTator, text mining | PubMed |
| Translatability scoring in prospective and retrospective COVID drug development cases. | Eur J Clin Pharmacol | 2023 | 37278822 | PubTator, text mining | PubMed |
| The increased cfRNA of TNFSF4 in peripheral blood at late gestation and preterm labor: its implication as a noninvasive biomarker for premature delivery. | Front Immunol | 2023 | 37275889 | PubTator, text mining | PubMed |
| The human Stat1 gain-of-function T385M mutation causes expansion of activated T-follicular helper/T-helper 1-like CD4 T cells and sex-biased autoimmunity in specific pathogen-free mice. | Front Immunol | 2023 | 37275873 | PubTator, text mining | PubMed |
| Machine learning applied in maternal and fetal health: a narrative review focused on pregnancy diseases and complications. | Front Endocrinol (Lausanne) | 2023 | 37274341 | PubTator, text mining | PubMed |
| COVID-19 Oral Sequelae: Persistent Gustatory and Saliva Secretory Dysfunctions after Recovery from COVID-19. | Med Princ Pract | 2023 | 37271130 | PubTator, text mining | PubMed |
| Cellular activation pathways and interaction networks in vascularized composite allotransplantation. | Front Immunol | 2023 | 37266446 | PubTator, text mining | PubMed |
| Biological mechanisms underpinning the development of long COVID. | iScience | 2023 | 37265584 | PubTator, text mining | PubMed |
| Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma. | Funct Integr Genomics | 2023 | 37264263 | PubTator, text mining | PubMed |
| Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas. | Haematologica | 2023 | 37259566 | PubTator, text mining | PubMed |
| An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma. | Respir Res | 2023 | 37259066 | PubTator, text mining | PubMed |
| The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma. | JCI Insight | 2023 | 37252795 | PubTator, text mining | PubMed |
| The Immune Microenvironment in Multiple Myeloma Progression at a Single-cell Level. | Hemasphere | 2023 | 37251913 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
| Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma. | Cancer Res | 2023 | 37249584 | PubTator, text mining | PubMed |
| Broad-Spectrum Antivirals Derived from Natural Products. | Viruses | 2023 | 37243186 | PubTator, text mining | PubMed |
Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma. | Int J Mol Sci | 2023 | 37240154 | PubTator, text mining | PubMed |
| The Interplay between T Cells and Cancer: The Basis of Immunotherapy. | Genes (Basel) | 2023 | 37239368 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=33